|
Age—years, median (IQR)
|
62.0 (47.0–79.0)
|
67.0 (36.0–76.0)
|
58.5 (47.0–83.0)
|
0.647
|
|
Male sex—no. (%)
|
13 (61.9 %)
|
8 (72.7 %)
|
5 (50 %)
|
0.387
|
|
Type of bystander-witness status—no. (%)
|
16 (76.2 %)
|
8 (72.7 %)
|
8 (80 %)
|
1.000
|
|
Bystander-initiated CPR—no. (%)
|
14 (66.7 %)
|
7 (72.7 %)
|
7 (70 %)
|
1.000
|
|
Cardiac origin—no. (%)
|
17 (81.0 %)
|
10
|
7
|
0.311
|
|
Initially documented rhythms on the scene of cardiac arrest—no.
| | | |
0.123
|
|
VF/pulseless VT
|
11
|
8
|
3
| |
|
Non-VF/pulseless VT
|
10
|
3
|
7
| |
|
Estimated interval from collapse to ROSC—min
|
16.5 (13.0–29.5)
|
13.5 (10.0–16.25)
|
23.5 (16.75–44.25)
|
0.014
|
|
Therapeutic hypothermia—no. (%)
|
14 (66.7 %)
|
9 (81.8 %)
|
5 (50 %)
|
0.183
|
|
Initial lactate—mmol L−1
| |
3.9 (2.4–7.5)
|
12.1 (7.08–15.70)
|
0.003
|
|
Initial NH3—μg dl−1
| |
90.0 (41.0–140.0)
|
221.0 (90.5–345.5)
|
0.025
|
|
Myoglobin (day 1)—ng ml−1
| |
402 (95–1343)
|
2008 (323–8358)
|
0.070
|
|
APACHE-II
| |
24 (15–29)
|
30 (26–37)
|
0.072
|
|
IL-6 (day 1)—pg ml−1
| |
23.5 (13.9–53.9)
|
88.0 (56.2–687.5)
|
0.024
|
|
Max IL-6—pg ml−1
| |
84.9 (45.8–119.0)
|
196.5 (82.4–30637.5)
|
0.087
|
|
Max JAAM DIC
| |
3.0 (2.0–4.0)
|
4.0 (2.0–6.25)
|
0.285
|
|
Max ISTH DIC
| |
3.0 (2.0–3.0)
|
3.0 (2.75–5.5)
|
0.338
|
|
Max SOFA
| |
10 (7.0–11.0)
|
10.0 (8.75–13.5)
|
0.499
|
|
Max d-dimer
| |
7.0 (4.9–25.1)
|
24.7 (4.9–25.1)
|
0.074
|
|
Neurological outcomes 30 days after OHCA
| | | | |
|
Survival (CPCs 1–4)—no. (%)
|
14 (66.7 %)
| | | |
|
CPC 1, good performance
|
9
| | | |
|
CPC 2, moderate disability
|
2
| | | |
|
CPC 3, severe disability
|
1
| | | |
|
CPC 4, vegetative state
|
2
| | | |
|
CPC 5, death
|
7
| | | |
